Artiva Biotherapeutics, Inc.'s total assets for Q4 2024 were $209.58M, a decrease of -7.10% from the previous quarter. ARTV total liabilities were $22.94M for the fiscal quarter, a -6.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.